Pasar al contenido principal

CITOESQUELETO E INFLAMACION EN INFECCIONES VIRALES: NUEVAS OPCIONES EN LA BUSQUEDA DE ANTIVIRALES DE AMPLIO ESPECTRO

PID2021-123399OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

  • López-Ayllón, Blanca D.
  • Marín, Silvia
  • Farinas Fernández, Marcos
  • García-García, Tránsito
  • Fernández-Rodríguez, Raúl
  • Lucas-Rius, Ana de
  • Redondo, Natalia
  • Mendoza-García, Laura
  • Foguet, Carles
  • Grigas, Juozas
  • Calvet, Alba
  • Villalba, José Manuel
  • Rodríguez Gómez, María Josefa
  • Megías, Diego
  • Mandracchia, Biagio
  • Lozano, Juan José
  • Calvo, Cristina
  • Thomson, Timothy M.
  • Garrido, Juan J.
  • Cascante, Marta
  • Montoya, María
Antiviral signaling, immune response and cell metabolism in human body are dysregulated by SARS-CoV-2, the causative agent of the COVID-19. Here, we show that SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 induce a significant mitochondrial and metabolic reprogramming in A549 lung epithelial cells. While all four ORFs caused mitochondrial fragmentation and altered mitochondrial function, only ORF3a and ORF9c induced a marked structural alteration in mitochondrial cristae. ORF9b, ORF9c and ORF10 induced largely overlapping transcriptomes. In contrast, ORF3a induced a distinct transcriptome, including the downregulation of numerous genes for proteins with critical mitochondrial functions and morphology. Genome-Scale Metabolic Models predicted common and private metabolic flux reprogramming, notably a depressed amino acid metabolism, and an enhanced metabolism of specific lipids distinctly induced by ORF3a. These findings reveal metabolic dependencies and vulnerabilities prompted by SARS-CoV-2 accessory proteins that may be exploited to identify new targets for intervention., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089), Spanish Ministry of Science project (PID2021-123399OB-I00), the Agency for Management of University and Research Grants from Generalitat de Catalunya-AGAUR (2020PANDE00048 and 2021SGR00350) and ICREA foundation (ICREA-Academia-2021 to MC) of Generalitat de Catalunya, and an AESi grant of the Instituto de Salud Carlos III (PI20CIII-00014). TGG is recipient of a Ramón y Cajal contract funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Individually expressed SARS-CoV-2 viroporin ORF3a alters inflammatory responses and cellular structure in lung epithelial cells

  • Lucas-Rius, Ana de
  • Zaldívar-López, Sara
  • Mendoza-García, Laura
  • López-Ayllón, Blanca D.
  • García-García, Tránsito
  • Redondo, Natalia
  • Fernández-Rodríguez, Raúl
  • Suárez-Cárdenas, José M.
  • Jiménez-Marín, Ángeles
  • Pérez-Berna, Ana Joaquina
  • Pereiro, Eva
  • Oliva, María A.
  • Garrido, Juan J.
  • Montoya, María
1 p.-6 fig., The SARS-CoV-2 coronavirus is the causative agent of the coronavirus disease 2019 (COVID-19). The clinical course of this respiratory disease exhibits a broad spectrum of severity and progression patterns, being potentially fatal. It is known that the underlying cause of severe disease is a cytokine dysregulation and hyperinflammation status. The SARS-CoV-2 genome encodes for eleven accessory proteins which, despite being non-essential for viral replication, may play important roles in viral pathogenesis, and even several variants of concern have mutations among them., ORF3a, the largest accessory protein, is a type III transmembrane protein that forms dimers. It is thought to be a viroporin and function as an ion channel, although this is currently under debate. It has been described to activate the NF-kB pathway and NLRP3 inflammasome, upregulate cytokine expression, induce oxidative stress and cell apoptosis, inhibit interferon-activated JAK/STAT pathway and reduce MHC-I levels among other functions, This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science project PID2021-123399OB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic and mitochondria alterations induced by SARS‐CoV‐2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

  • López-Ayllón, Blanca D.
  • Marín, Silvia
  • Farinas Fernández, Marcos
  • García-García, Tránsito
  • Fernández-Rodríguez, Raúl
  • Lucas-Rius, Ana de
  • Redondo, Natalia
  • Mendoza, Laura
  • Foguet, Carles
  • Grigas, Juozas
  • Calvet, Alba
  • Villalba, José Manuel
  • Rodríguez Gómez, María Josefa
  • Megías, Diego
  • Mandracchia, Biagio
  • Luque, Daniel
  • Lozano, Juan José
  • Calvo, Cristina
  • Merino Herrán, Unai
  • Thomson, Timothy M.
  • Garrido, Juan J.
  • Cascante, Marta
  • Montoya, María
22 p.-8 fig., Antiviral signaling, immune response and cell metabolism are dysregulated by SARS-CoV-2, the causative agent of COVID-19. Here, we show that SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 induce a significant mitochondrial and metabolic reprogramming in A549 lung epithelial cells. While ORF9b, ORF9c and ORF10 induced largely overlapping transcriptomes, ORF3a induced a distinct transcriptome, including the downregulation of numerous genes with critical roles in mitochondrial function and morphology. On the other hand, all four ORFs altered mitochondrial dynamics and function, but only ORF3a and ORF9c induced a marked alteration in mitochondrial cristae structure. Genome-Scale Metabolic Models identified both metabolic flux reprogramming features both shared across all accessory proteins and specific for each accessory protein. Notably, a downregulated amino acid metabolism was observed in ORF9b, ORF9c and ORF10, while an upregulated lipid metabolism was distinctly induced by ORF3a. These findings reveal metabolic dependencies and vulnerabilities prompted by SARS-CoV-2 accessory proteins that may be exploited to identify new targets for intervention., This research work was funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089), Spanish Ministry of Science project (PID2021-123399OB-I00), the Agency for Management of University and Research Grants from Generalitat de Catalunya-AGAUR (2020PANDE00048 and 2021SGR00350) and ICREA foundation (ICREA-Academia-2021 to MC) of Generalitat de Catalunya, and an AESi grant of the Instituto de Salud Carlos III (PI20CIII-00014). SM is Serra Húnter Fellow. TGG is recipient of a Ramón y Cajal contract funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2

  • López-Ayllón, Blanca D.
  • Mendoza-García, Laura
  • Lucas-Rius, Ana de
  • García-García, Tránsito
  • Fernández-Rodríguez, Raúl
  • Romero-Guillén, Antonio
  • Serrat, Judit
  • Zúñiga Lucas, Sonia
  • Redondo, Natalia
  • Siles Lucas, Mar
  • Garrido, Juan J.
  • Montoya, María
From the early days of the COVID-19 pandemic, an excessive release of proinflammatory cytokines, such as IL6, was detected in serum from patients. As a consequence, several anti-inflammatory drugs, such as Dexamethasone (a strong corticoid), were used to counteract such cytokine storm occurring during severe disease. By contrast, pro-inflammatory interleukin 11 (IL11), a member of the IL6 family, was detected in respiratory tissues from infected patients and in experimental epithelial cellular models. In this work, human A549 lung epithelial cells were individually transduced with SARS-CoV-2 open reading frames (ORFs), resulting in a IL11 increase, which was significantly decreased after Dexamethasone treatment. The use of this cellular platform allowed us to screen for new possible anti-inflammatory compounds from Fasciola hepatica. Our results highlighted the ability of FhNEJ (Fasciola hepatica newly excysted juvenile flukes) somatic extract to decrease IL11 levels in ORF-transduced cells. These results emphasized the role of IL11 in lung epithelial inflammation, making it a potential target for future treatments of lung inflammation which occurs in COVID-19, and validate the use of these ORF-expressing cells as a cellular platform to test anti-inflammatory compounds for COVID-19 disease., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science project (PID2021-123399OB-I00). TGG is recipient of a Ramón y Cajal contract funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR. This research work was also supported in part by the European Commission— Next Generation EU fund (Regulation EU 2020/2094), awarded to M.S.-L. through CSIC’s Global Health Platform (PTI Salud Global). M.S.-L. acknowledges the financial support of the Spanish Ministry of Science and Innovation (Project PID2019-108782RB365 C22), and the Project “CLU-2019-05—IRNASA/CSIC Unit of Excellence”, funded by the Junta de Castilla y León and co-financed by the European Union (ERDF “Europe drives our growth”). J.S. acknowledges the support of the Junta de Castilla y León for her Predoctoral contract., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors

  • Zodda, Erika
  • Pons, Mònica
  • DeMoya-Valenzuela, Natàlia
  • Calvo-González, Cristina
  • Benítez-Rodríguez, Cristina
  • López-Ayllón, Blanca D.
  • Hibot, Achraf
  • Zuin, Alice
  • Crosas, Bernat
  • Cascante, Marta
  • Montoya, María
  • Pujol, Maria Dolors
  • Rubio-Martínez, Jaime
  • Thomson, Timothy M.
Viral accessory proteins play critical roles in viral escape from host innate immune responses and in viral inflammatory pathogenesis. Here we show that the SARS-CoV-2 accessory protein, ORF9b, but not other SARS-CoV-2 accessory proteins (ORF3a, ORF3b, ORF6, ORF7, ORF8, ORF9c, and ORF10), strongly activates inflammasome-dependent caspase-1 in A549 lung carcinoma cells and THP-1 monocyte-macrophage cells. Exposure to lipopolysaccharide (LPS) and ATP additively enhanced the activation of caspase-1 by ORF9b, suggesting that ORF9b and LPS follow parallel pathways in the activation of the inflammasome and caspase-1. Following rational in silico approaches, we have designed small molecules capable of inhibiting the homodimerization of ORF9b, which experimentally inhibited ORF9b-ORF9b homotypic interactions, caused mitochondrial eviction of ORF9b, inhibited ORF9b-induced activation of caspase-1 in A549 and THP-1 cells, cytokine release in THP-1 cells, and restored type I interferon (IFN-I) signaling suppressed by ORF9b in both cell models. These small molecules are first-in-class compounds targeting a viral accessory protein critical for viral-induced exacerbated inflammation and escape from innate immune responses, with the potential of mitigating the severe immunopathogenic damage induced by highly pathogenic coronaviruses and restoring antiviral innate immune responses curtailed by viral infection., This work was funded by the Spanish National Research Council (CSIC, project numbers CSIC-COV19-006, CSIC-COV-19-201, CSIC-COV-19-117, SGL2103019, SGL2103015, 202020E079, 202320E187 and LINCGLOBAL INCGL20009), the Catalan Agency for Management of University and Research Grants (AGAUR, 2020PANDE00048, 2021SGR1490, 2021SGR00350), the Spanish Ministry of Science (PID2021-123399OB-I00), the CSIC's Global Health Platform (PTI Salud Global), The Networked Center for Biomedical Research in Liver and Digestive Diseases (CIBER-EHD), the Spanish Structures and Excellence María de Maeztu program (CEX2021-001202-M), the European Commission-Next Generation EU (Regulation EU 2020/2094), and INDICASAT-AIP., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins

  • Padilla-Blanco, Miguel
  • García-García, Tránsito
  • Grigas, Juozas
  • López-Ayllón, Blanca D.
  • Garrido, Juan J.
  • Oliva, María A.
  • Montoya, María
SARS-CoV-2 accessory proteins (APs), particularly ORF3a and ORF9b, have emerged as key modulators of host-pathogen interaction and potential contributors to long COVID. Of the 13 predicted APs, only nine are expressed during infection - termed Infection-related APs - while the remaining are classified as Putative APs. Despite this distinction, extensive gene overlap among APs underscores the remarkable adaptability of SARS-CoV-2 viral genome. This review delves into the diverse roles of the original Wuhan APs and their Omicron counterparts in shaping host immunity, with an emphasis on their ability to suppress type I interferon (IFN-I) signalling, modulate cellular metabolism, and trigger inflammatory/apoptotic pathways. By integrating immunopathological insights with evolutionary dynamics and structural perspectives, this review provides a comprehensive understanding of the mechanism underlying Omicron's reduced pathogenicity and highlights promising, yet unexplored, therapeutic targets within the SARS-CoV-2 accessory proteome., The author(s) declare financial support was received for the research and/or publication of this article. This research work was funded by the European Commission -NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089), Spanish Ministry of Science project (PID2021-123399OB-I00, CNS2023-145079 and PID2024-162356OB-I00) and the Research Council of Lithuania (LMTLT), agreement No.S-PD-24-110. TGG is recipient of a Ramón y Cajal contract (RYC2021-031614-I) funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An atlas of microtubule lattice parameters regulated through ligand binding to the microtubule-stabilizing sites

  • Lucena-Agell, Daniel
  • Fernández, Óscar
  • París-Ogáyar, Rebeca
  • Estévez-Gallego, Juan
  • Ondrúšková, Denisa
  • Álvarez-Bernad, Beatriz
  • Bonato, Francesca
  • Larraga, Jaime
  • Ortíz de Elguea, Diego
  • Cano, Gregorio Javier
  • Scheers, Maarten
  • Imai, Hiroshi
  • Yagi, Toshiki
  • Iwamoto, Hiroyuki
  • Carlos Martínez-Guil, Juan
  • Singh, A. Jonathan
  • Keyzers, Robert Alexander
  • Vanderwal, Christopher D.
  • Altmann, Karl-Heinz
  • Van der Eycken, Johan
  • Palomo, Valle
  • Fang, Wei-Shuo
  • Gago, Federico
  • Lánský, Zdeněk
  • Braun, Marcus
  • Oliva, María A.
  • Kamimura, Shinji
  • Díaz, José Fernando
Microtubules are dynamic cytoskeletal polymers whose lattice architecture regulates force generation, nucleotide hydrolysis, and recognition by motor proteins and microtubule-associated proteins (MAPs). Microtubule-stabilizing agents (MSAs), including taxanes and laulimalide/peloruside-site ligands, suppress depolymerization by binding to defined lattice sites, yet stabilization is not structurally neutral. How ligand chemistry reshapes lattice organization and function remains unresolved. Here, we address three mechanistic questions. First, do distinct ligand classes induce defined lattice states? Using X-ray fiber diffraction, we show that MSAs selectively stabilize two preferred longitudinal conformations, a compact state (~4.06 nm monomer rise) and an expanded state (~4.17 nm), while modulating lateral organization reflected in shifts in mean MT radius. These axial spacings cluster around discrete values across chemotypes, indicating stabilization of preexisting conformational minima rather than continuous distortion. Second, are these states interconvertible upon changes in ligand occupancy? Time-resolved diffraction reveals that longitudinal transitions occur within seconds of ligand addition even at substoichiometric occupancy, whereas, lateral equilibration proceeds slower, consistent with redistribution within heterogeneous protofilament organizations. Third, do such structural states alter nucleotide hydrolysis and motor/MAP behavior? Expanded lattices are associated with reduced apparent GTP hydrolysis rates under steady-state assembly conditions and altered kinesin motility, whereas compact lattices preferentially promote tau binding and distinct motor interaction profiles. Together, these findings establish longitudinal lattice conformation as a regulatory parameter and position MSAs as chemical tools that bias a dynamic structural landscape with predictable catalytic and transport consequences., This work was supported by the Ministerio de Ciencia e Innovación (MICIN) and FEDER (PID2022-136765OB-I00 to J.F.D. and PID2021-123399OB-I00 to M.A.O.), by the European Molecular Biology Organization (EMBO) through a Short-Term Fellowship (No. 11234 to R.P.-O.), and by MOSBRI (TNA) under project number MOSBRI-2024-296 to R.P.-O. We thank the staff of beamline BL11-NCD-SWEET at the ALBA Synchrotron (Cerdanyola del Vallès, Spain) for excellent technical support. Time-resolved kinetic experiments were performed with the approval of the SPring-8 Proposal Review Committee (proposal numbers 2016B1182, 2020A1332, and 2021A1430). We also gratefully acknowledge Ganadería Fernando Díaz for the supply of calf brains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition

  • Fernández-Rodríguez, Raúl
  • Soto-Jiménez, Carmen M
  • Acín-Pérez, Rebeca
  • Lucas-Rius, Ana de
  • Padilla-Blanco, Miguel
  • Sánchez-Mendoza, Luz M.
  • López-Ayllón, Blanca D.
  • Peralbo-Molina, Ángela
  • Chicano-Gálvez, Eduardo
  • Villalba, José M.
  • Enríquez, José Antonio
  • Montoya, María
  • Garrido, Juan J.
  • García-García, Tránsito
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection reprograms host metabolism to favor viral replication and immune evasion, yet the contribution of accessory proteins remains poorly defined. Here, we characterize the metabolic effects of the SARS-CoV-2 accessory protein ORF7a. Lentiviral expression of ORF7a in human lung epithelial (A549) and monocytic (THP1) cells, combined with integrated transcriptomic, proteomic, and metabolomic analyses, revealed marked dysregulation of glucose and lipid metabolism. ORF7a impaired mitochondrial oxidative phosphorylation, reducing basal and maximal respiration, inducing mitochondrial depolarization, and increasing reactive oxygen species. Mechanistically, ORF7a upregulated pyruvate dehydrogenase kinase 4 (PDK4), enhancing phosphorylation of the pyruvate dehydrogenase complex and suppressing pyruvate oxidation. However, pharmacological PDK4 inhibition failed to restore respiratory function. High-resolution respirometry identified complex I dysfunction, while Blue Native-PAGE revealed defective assembly of respiratory supercomplexes. Together, these findings demonstrate that ORF7a disrupts mitochondrial metabolism through enzymatic regulation and destabilization of the respiratory chain, highlighting mitochondria as a target of SARS-CoV-2-induced metabolic reprogramming., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094) through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science projects (PID2021-123399OB-I00 and PID2024-162356OB-I00). TGG is recipient of a Ramón y Cajal contract (RYC2021-031614-I) funded by MCIN/AEU/10.13039/501100011033 and NextGenerationEU/PRTR. RFR is a recipient of a “Contrato Predoctoral para Personal Investigador en Formación (PIF),” University of Córdoba, and has been supported by a PTI + Salud Global fellowship to undertake a predoctoral stay. LMSM was funded by BIO276 (University of Córdoba and Junta de Andalucía). We would like to thank Eduardo Chicano-Galvez and Ángela Peralbo-Molina from IMIBIC Mass Spectrometry and Molecular Imaging Unit (IMSMI) for performing the metabolomic analysis; Carlos Fuentes-Almagro from the Proteomics Facility at Research Support Central Service, University of Cordoba (SCAI-UCO), for sample preparation and proteomic analysis; and Sonia Zuñiga from CNB for kindly providing RNA samples from SARS-CoV-2 infected A549-ACE2 cells., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 ORF8 Exploits Host miRNA Networks to Rewire Post-Transcriptional Regulation

  • Fernández-Rodríguez, Raúl
  • Suárez-Cárdenas, José M.
  • Romero-Guillén, Antonio
  • López-Ayllón, Blanca D.
  • Santos, Fátima Milhano
  • Lucas-Rius, Ana de
  • Merino-Herrán, Unai
  • Corrales, Fernando J.
  • Montoya, María
  • Garrido, Juan J.
  • García-García, Tránsito
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes several accessory proteins that modulate host cellular pathways and contribute to immune evasion and disease severity. Among them, ORF8 has emerged as a key immunomodulatory factor; however, its impact on host post-transcriptional regulatory networks remains poorly defined. In this study, we investigated how ORF8 expression reshapes the microRNA (miRNA) landscape of lung epithelial cells and how these changes translate into functional proteomic alterations. Using A549 cells transduced with ORF8 and control cells, we performed small RNA sequencing to identify differentially expressed miRNAs, followed by integrative analysis with quantitative proteomic data. ORF8 expression induces extensive remodeling of the miRNA profile, with coordinated upregulation and downregulation of miRNAs involved in inflammatory signaling, interferon regulation, apoptosis, autophagy and epithelial homeostasis. Integration of miRNA and proteomic datasets revealed inverse regulatory relationships linking ORF8-associated miRNAs to proteins involved in immune defense, stress responses and epithelial integrity. Selected miRNA alterations were validated by RT-qPCR, and the junctional protein plakoglobin (JUP) was experimentally confirmed as a representative downregulated target. Collectively, our findings identify ORF8 as a factor associated with coordinated miRNA-mediated post-transcriptional reprogramming in lung epithelial cells. This network-based regulatory framework provides new insight into how SARS-CoV-2 accessory proteins may influence host responses and highlights miRNA networks as potential contributors to viral pathogenesis and host immune dysregulation., This research work was funded by the European Commission—NextGenerationEU (Regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science projects (PID2021-123399OB-I00 and PID2024-162356OB-I00). TGG is a recipient of a Ramón y Cajal contract (RYC2021-031614-I) funded by MCIN/AEU/10.13039/501100011033 and NextGeneration EU/PRTR. RFR is a recipient of a Contrato Predoctoral para Personal Investigador en Formación (PIF-2023), University of Córdoba. A.L-R. is a recipient of an Ayuda para la contratación de Personal Investigador Predoctoral en Formación (PIPF-2022/SAL-GL-25558, CAM)., Peer reviewed